Gene · 6472
Papers2,556
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,556
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| USP32 deubiquitinase: cellular functions, regulatory mechanisms, and potential as a cancer therapy target. | Cell Death Discov | 2023 | 37679322 | PubTator, text mining | PubMed |
| Construction of an aging-related risk signature in high-grade serous ovarian cancer for predicting survival outcome and immunogenicity. | Medicine (Baltimore) | 2023 | 37657028 | PubTator, text mining | PubMed |
| Identification of potential biomarkers and candidate therapeutic drugs for clear cell renal cell carcinoma by bioinformatic analysis and reverse network pharmacology. | Medicine (Baltimore) | 2023 | 37657024 | PubTator, text mining | PubMed |
| Aminooxy acetic acid suppresses Th17-mediated psoriasis-like skin inflammation by inhibiting serine metabolism. | Front Pharmacol | 2023 | 37649889 | PubTator, text mining | PubMed |
| A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine glioma. | Front Oncol | 2023 | 37637064 | PubTator, text mining | PubMed |
| Tryptophan metabolite norharman secreted by cultivated Lactobacillus attenuates acute pancreatitis as an antagonist of histone deacetylases. | BMC Med | 2023 | 37635214 | PubTator, text mining | PubMed |
| Natural and Synthetic Anticancer Epidrugs Targeting the Epigenetic Integrator UHRF1. | Molecules | 2023 | 37630248 | PubTator, text mining | PubMed |
| Case report: Severe nonketotic hyperglycinemia in a neonate without apparent seizures but concomitant cleft palate and cerebral sinovenous thrombosis. | Front Pediatr | 2023 | 37614902 | PubTator, text mining | PubMed |
| Mitochondrial heterogeneity in diseases. | Signal Transduct Target Ther | 2023 | 37607925 | PubTator, text mining | PubMed |
| Genetics of enzymatic dysfunctions in metabolic disorders and cancer. | Front Oncol | 2023 | 37601653 | PubTator, text mining | PubMed |
| One-carbon metabolizing enzyme ALDH1L1 influences mitochondrial metabolism through 5-aminoimidazole-4-carboxamide ribonucleotide accumulation and serine depletion, contributing to tumor suppression. | Sci Rep | 2023 | 37596270 | PubTator, text mining | PubMed |
| Methionine orchestrates the metabolism vulnerability in cisplatin resistant bladder cancer microenvironment. | Cell Death Dis | 2023 | 37582769 | PubTator, text mining | PubMed |
| Structure-Based Design of Transport-Specific Multitargeted One-Carbon Metabolism Inhibitors in Cytosol and Mitochondria. | J Med Chem | 2023 | 37582241 | PubTator, text mining | PubMed |
| Co-inhibition of glutaminolysis and one-carbon metabolism promotes ROS accumulation leading to enhancement of chemotherapeutic efficacy in anaplastic thyroid cancer. | Cell Death Dis | 2023 | 37573361 | PubTator, text mining | PubMed |
| Environmental Determinants of Ferroptosis in Cancer. | Cancers (Basel) | 2023 | 37568677 | PubTator, text mining | PubMed |
| Comprehensive analysis of the immunogenic cell death-related signature for predicting prognosis and immunotherapy efficiency in patients with lung adenocarcinoma. | BMC Med Genomics | 2023 | 37553698 | PubTator, text mining | PubMed |
| Two antisense RNAs-AFAP1-AS1 and MLK7-AS1-promote colorectal cancer progression by sponging miR-149-5p and miR-485-5p. | Mol Ther Nucleic Acids | 2023 | 37547289 | PubTator, text mining | PubMed |
| Circulating circRNA: a social butterfly in tumors. | Front Oncol | 2023 | 37546422 | PubTator, text mining | PubMed |
| Mangiferin is a new potential antimalarial and anticancer drug for targeting serine hydroxymethyltransferase. | Arch Biochem Biophys | 2023 | 37543353 | PubTator, text mining | PubMed |
| Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex. | J Biol Chem | 2023 | 37536630 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6472/papers?page=11